Assess the Risk of Cerebrovascular Disease

RecruitingOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

October 9, 2020

Primary Completion Date

November 15, 2026

Study Completion Date

December 1, 2026

Conditions

Cerebrovascular Disease

Interventions

DEVICE

GE Discovery MR750 3.0t superconducting MRI

T2WI, FLAIR, DWI, 3D BRAVO, 3D-ASL, rs-fMRI, DKI sequences to exclude other organic lesions

Trial Locations (1)

RECRUITING

Wen Wang, Xi'an

All Listed Sponsors

lead

Tang-Du Hospital

OTHER